MetLife (MET) Director Carla A. Harris Receives 42-Share Award

What Happened
Carla A. Harris, a director of MetLife, received 42 shares on 2026-09-08 as an award/acquisition (transaction code A) at an imputed price of $95.50 per share, for a total value of approximately $4,011. The filing indicates these are deferred shares credited under MetLife’s deferred compensation arrangements for non‑management directors.

Key Details

• Transaction date and price: 2026-09-08; 42 shares at $95.50 per share.
• Total value: ≈ $4,011.
• Shares owned after transaction: not specified in this Form 4.
• Footnote: F1 — imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non‑Management Directors (shares became payable but were deferred).
• Filing: Form 4 filed 2026-09-10 (filed within the normal 2‑business‑day window; appears timely).

Context
This is a routine crediting of deferred shares (imputed dividend reinvestment) under a director compensation plan, not an open‑market purchase or sale. Such awards are typically part of standard director pay and do not by themselves indicate a change in an insider’s market view.